Prognostic value of impaired estimated glomerular filtration rate in intravesical BCG-treated non–muscle-invasive bladder cancer patients

Abstract To evaluate the influence of patient-associated parameters and comorbities, with a special focus on renal function after intravesical adjuvant bacillus Calmette-Gue´rin (BCG) immunotherapy in patients with non–muscle-invasive bladder cancer (NMIBC). We retrospectively reviewed the medical r...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Bum Sik Tae, Jung Kwon Kim, Minyong Kang, Chang Wook Jeong, Cheol Kwak, Hyeon Hoe Kim, Ja Hyeon Ku
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/361e0f802b4946569d4467a1cd3785ac
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:361e0f802b4946569d4467a1cd3785ac
record_format dspace
spelling oai:doaj.org-article:361e0f802b4946569d4467a1cd3785ac2021-12-02T11:52:31ZPrognostic value of impaired estimated glomerular filtration rate in intravesical BCG-treated non–muscle-invasive bladder cancer patients10.1038/s41598-017-01532-72045-2322https://doaj.org/article/361e0f802b4946569d4467a1cd3785ac2017-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-01532-7https://doaj.org/toc/2045-2322Abstract To evaluate the influence of patient-associated parameters and comorbities, with a special focus on renal function after intravesical adjuvant bacillus Calmette-Gue´rin (BCG) immunotherapy in patients with non–muscle-invasive bladder cancer (NMIBC). We retrospectively reviewed the medical records of patients treated from October, 1991 to December, 2013 at Seoul National University who were diagnosed with NMIBC and treated with intravesical BCG. A total of 344 patients who were diagnosed with NMIBC and treated with intravesical BCG were enrolled in this study. Tumor recurrence was observed in 171 patients (49.3%); progression to higher pT category or grade was found in 68 patients (15.1%). Multivariate analysis demonstrated that recurrent tumors and the presence of multiple tumors increased the risk of recurrence. However, other factors also appeared to predict recurrence, such as impaired renal function (<60 ml/min), which was associated with recurrence in univariate and multivariate analyses (HR 1.879 p = 0.008). It is worthy of notice that impaired renal function was an independent predictor of tumor recurrence after BCG instillation in multivariate analysis. Therefore, we should consider not only the clinical or pathologic findings of a tumor but also renal function during decision-making for additional therapy.Bum Sik TaeJung Kwon KimMinyong KangChang Wook JeongCheol KwakHyeon Hoe KimJa Hyeon KuNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-8 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Bum Sik Tae
Jung Kwon Kim
Minyong Kang
Chang Wook Jeong
Cheol Kwak
Hyeon Hoe Kim
Ja Hyeon Ku
Prognostic value of impaired estimated glomerular filtration rate in intravesical BCG-treated non–muscle-invasive bladder cancer patients
description Abstract To evaluate the influence of patient-associated parameters and comorbities, with a special focus on renal function after intravesical adjuvant bacillus Calmette-Gue´rin (BCG) immunotherapy in patients with non–muscle-invasive bladder cancer (NMIBC). We retrospectively reviewed the medical records of patients treated from October, 1991 to December, 2013 at Seoul National University who were diagnosed with NMIBC and treated with intravesical BCG. A total of 344 patients who were diagnosed with NMIBC and treated with intravesical BCG were enrolled in this study. Tumor recurrence was observed in 171 patients (49.3%); progression to higher pT category or grade was found in 68 patients (15.1%). Multivariate analysis demonstrated that recurrent tumors and the presence of multiple tumors increased the risk of recurrence. However, other factors also appeared to predict recurrence, such as impaired renal function (<60 ml/min), which was associated with recurrence in univariate and multivariate analyses (HR 1.879 p = 0.008). It is worthy of notice that impaired renal function was an independent predictor of tumor recurrence after BCG instillation in multivariate analysis. Therefore, we should consider not only the clinical or pathologic findings of a tumor but also renal function during decision-making for additional therapy.
format article
author Bum Sik Tae
Jung Kwon Kim
Minyong Kang
Chang Wook Jeong
Cheol Kwak
Hyeon Hoe Kim
Ja Hyeon Ku
author_facet Bum Sik Tae
Jung Kwon Kim
Minyong Kang
Chang Wook Jeong
Cheol Kwak
Hyeon Hoe Kim
Ja Hyeon Ku
author_sort Bum Sik Tae
title Prognostic value of impaired estimated glomerular filtration rate in intravesical BCG-treated non–muscle-invasive bladder cancer patients
title_short Prognostic value of impaired estimated glomerular filtration rate in intravesical BCG-treated non–muscle-invasive bladder cancer patients
title_full Prognostic value of impaired estimated glomerular filtration rate in intravesical BCG-treated non–muscle-invasive bladder cancer patients
title_fullStr Prognostic value of impaired estimated glomerular filtration rate in intravesical BCG-treated non–muscle-invasive bladder cancer patients
title_full_unstemmed Prognostic value of impaired estimated glomerular filtration rate in intravesical BCG-treated non–muscle-invasive bladder cancer patients
title_sort prognostic value of impaired estimated glomerular filtration rate in intravesical bcg-treated non–muscle-invasive bladder cancer patients
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/361e0f802b4946569d4467a1cd3785ac
work_keys_str_mv AT bumsiktae prognosticvalueofimpairedestimatedglomerularfiltrationrateinintravesicalbcgtreatednonmuscleinvasivebladdercancerpatients
AT jungkwonkim prognosticvalueofimpairedestimatedglomerularfiltrationrateinintravesicalbcgtreatednonmuscleinvasivebladdercancerpatients
AT minyongkang prognosticvalueofimpairedestimatedglomerularfiltrationrateinintravesicalbcgtreatednonmuscleinvasivebladdercancerpatients
AT changwookjeong prognosticvalueofimpairedestimatedglomerularfiltrationrateinintravesicalbcgtreatednonmuscleinvasivebladdercancerpatients
AT cheolkwak prognosticvalueofimpairedestimatedglomerularfiltrationrateinintravesicalbcgtreatednonmuscleinvasivebladdercancerpatients
AT hyeonhoekim prognosticvalueofimpairedestimatedglomerularfiltrationrateinintravesicalbcgtreatednonmuscleinvasivebladdercancerpatients
AT jahyeonku prognosticvalueofimpairedestimatedglomerularfiltrationrateinintravesicalbcgtreatednonmuscleinvasivebladdercancerpatients
_version_ 1718394976689192960